Key facts
- Aidin’s last known valuation is $42.0M (Aug 2025).
- It has raised $8.7M; the latest was Later Stage VC ($3.5M) in Aug 2025.
- Notable investors include Techstars, General Catalyst, Charles Songhurst, Red Swan Ventures, Romulus Capital — 21 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 21 names
- ·Watchlist + deal alerts for Aidin
- ·The full record, as it builds
Funding rounds
No funding rounds for Aidin are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Aidin
Developer of a patient post-acute care management platform designed to defragment the healthcare ecosystem by connecting providers and patients. The company's platform aids patients in making the right choice post-hospital by providing them with up-to-date ratings and reviews of the available providers in their area and giving them data on the outcomes of each provider's patients, enabling hospital social workers and case managers to discharge patients, decrease readmissions, and improve satisfaction.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2011
- Employees
- 45
- Website
- myaidin.com/
- Ownership
- Privately Held (backing)
Aidin doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aidin shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aidin in its N-PORT filings yet. We sweep new filings monthly.